IL-1β is essential for Langerhans cell activation and antigen delivery to the lymph nodes during contact sensitization:: Evidence for a dermal source of IL-1β

被引:33
作者
Shornick, LP [1 ]
Bisarya, AK
Chaplin, DD
机构
[1] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA
关键词
skin; dendritic cell; antigen presentation; cytokine; Langerhans cell; interleukin-1; beta;
D O I
10.1006/cimm.2001.1834
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IL-1 beta (-/-) mice manifest an impaired contact hypersensitivity response to the hapten trinitrochlorobenzene, with the principle defect expressed during the sensitization phase of this response. Following application of hapten to the skin, epidermal Langerhans cells of IL-beta (-/-) mice failed to demonstrate the classical phenotype of activation. In addition, the delivery of epicutaneously applied fluorescein isothiocyanate to draining lymph nodes was decreased in IL-1 beta (-/-) mice. Hapten delivery to draining lymph nodes could be restored by intradermal injection of recombinant IL-1 beta. Reconstitution of lethally irradiated IL-1 beta (-/-) mice by transfer of wild-type bone marrow restored hapten-stimulated IL-1 beta mRNA expression, demonstrating that IL-1 beta production was dependent on bone marrow-derived cells. In wild-type skin, IL-1 beta expression was upregulated in a time- and dose-dependent fashion following hapten application. Interestingly, prominent IL-1 beta expressing cells were found in the dermis, suggesting that dermal cells may contribute significantly to the contact hypersensitivity response. (C) 2001 Academic Press.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 34 条
[1]  
AIBA S, 1990, J IMMUNOL, V145, P2791
[2]  
ANSEL JC, 1988, J IMMUNOL, V140, P2274
[3]   INTERLEUKIN-1-BETA CONVERTING-ENZYME IN MURINE LANGERHANS CELLS AND EPIDERMAL-DERIVED DENDRITIC CELL-LINES [J].
ARIIZUMI, K ;
KITAJIMA, T ;
BERGSTRESSER, PR ;
TAKASHIMA, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) :2137-2141
[4]   IA+ MURINE EPIDERMAL LANGERHANS CELLS ARE DEFICIENT IN SURFACE EXPRESSION OF THE CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX [J].
CAUGHMAN, SW ;
SHARROW, SO ;
SHIMADA, S ;
STEPHANY, D ;
MIZUOCHI, T ;
ROSENBERG, AS ;
KATZ, SI ;
SINGER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7438-7442
[5]   OCCURRENCE OF DONOR LANGERHANS CELLS IN MOUSE AND RAT CHIMERAS AND THEIR REPLACEMENT IN SKIN-GRAFTS [J].
CHEN, HD ;
MA, CL ;
YUAN, JT ;
WANG, YK ;
SILVERS, WK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 86 (06) :630-633
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]   Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration [J].
Cumberbatch, M ;
Dearman, RJ ;
Kimber, I .
IMMUNOLOGY, 1997, 92 (03) :388-395
[8]  
ENK AH, 1993, J IMMUNOL, V150, P3698
[9]   EARLY MOLECULAR EVENTS IN THE INDUCTION-PHASE OF CONTACT SENSITIVITY [J].
ENK, AH ;
KATZ, SI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1398-1402
[10]   PRESENCE OF EPIDERMAL-DERIVED THYMOCYTE ACTIVATING FACTOR INTERLEUKIN-1 IN NORMAL HUMAN STRATUM-CORNEUM [J].
GAHRING, LC ;
BUCKLEY, A ;
DAYNES, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) :1585-1591